🔎 Trials Near Me

Home › Steatotic Liver Disease › Washington › Seattle

Steatotic Liver Disease clinical trials in Seattle, WA

7 studies for Steatotic Liver Disease are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)

RecruitingPhase 3
  • UW Medicine Diabetes Institute, Seattle
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07165028

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

RecruitingPhase 3
  • Akero Clinical Study Site, Seattle
Ages 18 to 80 · All sexes · Updated Sep 21, 2026 · NCT06528314

A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH

RecruitingPhase 3
  • GSK Investigational Site, Seattle
Ages 18 to 75 · All sexes · Updated Sep 17, 2026 · NCT07221188

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

RecruitingPhase 3
  • 89bio Clinical Study Site, Seattle
  • 89bio Clinical Study Site, Seattle
Ages 18 to 75 · All sexes · Updated Sep 3, 2026 · NCT06419374

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

RecruitingPhase 3
  • 89bio Clinical Study Site, Seattle
  • 89bio Clinical Study Site, Seattle
Ages 18 to 80 · All sexes · Updated Sep 3, 2026 · NCT06318169

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

RecruitingPhase 3
  • GSK Investigational Site, Seattle
Ages 18 to 75 · All sexes · Updated Jul 27, 2026 · NCT07221227

Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

RecruitingHealthy volunteers welcome
  • University of Washington, Seattle
Ages 18 to 75 · All sexes · Updated Dec 8, 2025 · NCT07270601

About Steatotic Liver Disease

Steatotic liver disease, formerly called fatty liver disease, happens when too much fat builds up in your liver. Learn about the causes and treatments.

More about Steatotic Liver Disease on MedlinePlus

Steatotic Liver Disease trials in other cities

Other studies in Seattle

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.